Evidence map›Paper›PMID 32698843›Full record

ArticleRadiation oncology (London, England)2020

Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.

Francesco Cuccia, Rosario Mazzola, Luca Nicosia, Vanessa Figlia, Niccolò Giaj-Levra, Francesco Ricchetti, Michele Rigo, Claudio Vitale, Beatrice Mantoan, Antonio De Simone and 4 more

Open access · goldAbstract read
In one paragraph

Article in Radiation oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Role of rectal spacers in gynecological cancer radiotherapy: reducing rectal dose and treatment-related toxicity.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Francesco CucciaAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy. f.cuccia1@virgilio.it.ORCID http://orcid.org/0000-0003-0390-9511
Rosario MazzolaAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Luca NicosiaAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Vanessa FigliaAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Niccolò Giaj-LevraAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Francesco RicchettiAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Michele RigoAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Claudio VitaleAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Beatrice MantoanAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Antonio De SimoneAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Gianluisa SicignanoAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Ruggero RuggieriAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Stefano CavalleriUrology Division, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Filippo AlongiAdvanced Radiation Oncology Deparment, Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Ospedale Sacro Cuore Don Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe assessment of organ motion is a crucial feature for prostate stereotactic body radiotherapy (SBRT). Rectal spacer may represent a helpful device in order to outdistance rectal wall from clinical target, but its impact on organ motion is still a matter of debate. MRI-Linac is a new frontier in radiation oncology as it allows a superior visualization of the real-time anatomy of the patient and the current highest level of adaptive radiotherapy.

methodsWe present data regarding a total of 100 fractions in 20 patients who underwent MRI-guided prostate SBRT for low-to-intermediate risk prostate cancer with or without spacer. Translational and rotational shifts were computed on the pre- and post-treatment MRI acquisitions referring to the delivery position for antero-posterior, latero-lateral and cranio-caudal direction, and assessed using the Mann-Whitney U-Test.

resultsAll patients were treated with a five sessions schedule (35 Gy/5fx) using MRI-Linac for a median fraction treatment time of 50 min (range, 46-65). In the entire study sample, median rotational displacement was 0.1° in cranio-caudal, - 0.002° in latero-lateral and 0.01° in antero-posterior direction; median translational shift was 0.11 mm in cranio-caudal, - 0.24 mm in latero-lateral and - 0.22 mm in antero-posterior. A significant difference between spacer and no-spacer patients in terms of rotational shifts in the antero-posterior direction (p = 0.033) was observed; also for translational shifts a positive trend was detected in antero-posterior direction (p = 0.07), although with no statistical significance. We observed statistically significant differences in the pre-treatment planning phase in favor of the spacer cohort for several rectum dose constraints: rectum V32Gy < 5% (p = 0.001), V28 Gy < 10% (p = 0.001) and V18Gy < 35% (p = 0.039). Also for bladder V35 Gy < 1 cc, the use of spacer provided a dosimetric advantage compared to the no-spacer subpopulation (p = 0.04). Furthermore, PTV V33.2Gy > 95% was higher in the spacer cohort compared to the no-spacer one (p = 0.036).

conclusionIn our experience, the application of rectal hydrogel spacer for prostate SBRT resulted in a significant impact on rotational antero-posterior shifts contributing to limit prostate intra-fraction motion. Further studies with larger sample size and longer follow-up are required to confirm this ideally favorable effect and to assess any potential impact on clinical outcomes.

Indexed as

AgedHumansHydrogelsMagnetic Resonance ImagingMaleMiddle AgedMotionOrgans at RiskProstatic NeoplasmsRadiosurgeryRadiotherapy DosageRadiotherapy, Image-GuidedRadiotherapy Planning, Computer-AssistedRectumHydrogelsMri-linacOrgan motionProstate cancerStereotactic body radiotherapy

Identifiers

PMID32698843
PMCPMC7376654
OpenAlexW3044172039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.